In Canada, 1 in 7 men are likely to be diagnosed with prostate cancer in their lifetime. Prostate Specific Antigen (PSA) testing is currently not recommended in Canada as population based screening test. Prostate cancer, like other tumors, disperses tumor cells into circulation. If effectively isolated, molecularly analyzed and characterized, CTCs are potentially a reliable […]
Read More